- Minimální reziduální nemoc u hematoonkologických malignit2020 | Second Faculty of Medicine
- Monitoring minimal residual disease in pediatric patients with acute lymphoblastic leukemia2000 | Second Faculty of Medicine
- Aetiology of childhood ALL and AML, molecular genetics and minimal residual disease2015 | Second Faculty of Medicine
- Detection of Minimal Residual Disease in Ewing's sarcoma Using RT-PCR2000 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Minimal residual disease – detection possibilities in haematological and non-haematological malignancies2013 | Second Faculty of Medicine
- Identification of new molecular markers for minimal residual disease assessment in acute leukemia patients2013 | First Faculty of Medicine, Third Faculty of Medicine
- Detectgion of minimal residual disease in acute lymphoblastic leukemia using quantification of immunoglobulin and T-cell receptor genes rearrangements. How to avoid misinterpretation of the results2005 | Second Faculty of Medicine
- Investigation of Minimal Residual Disease in Patients with Hairy Cell Leukemia in Complete Remission after Treatment with 2-chlorodeoxyadenosine2000 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Minimal residual disease in chronic lymphocytic leukemia: Detection methods and clinical significance2010 | Third Faculty of Medicine
- Immunohistochemical Detection and Quantification of Minimal Residual Disease with the Use of DBA.44 Antibody in Trephine Bone Marrow Biopsies of Patients with Hairy Cell Leukemia2003 | First Faculty of Medicine
- Personalized medicine in haematooncology - the pathologist's perspective2010 | Second Faculty of Medicine
- Laboratory testing for the presence of minimal residual disease using DNA-based RQ-PCR for clonal rearrangements of Ig/TCR defined by PCR or massive parallel sequencing (NGS)Publication without faculty affiliation
- Assessment of extramedullary leukemic infiltration in childhood acute lymphoblastic leukemia and its clinical use. Review and original data2012 | First Faculty of Medicine, Faculty of Physical Education and Sport, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Immunohistochemical Detection and Quantification of Minimal Residual Disease with the Use of DBA.44 Antibody in Trephine Bone Marrow Biopsies of Patients with Hairy Cell Leukemia2003 | Faculty of Medicine in Hradec Králové
- Reality investigation of minimal residual disease in acute leukemia or how laboratory acrobatics is really necessary?2013 | Second Faculty of Medicine
- Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia1999 | Second Faculty of Medicine
- Analysis of minimal residual disease (MRD) of protocol ALL IC - BFM 2002: Might the patients be stratified without MRD? +1Publication without faculty affiliation
- Assessment of extramedullary leukemic infiltration in childhood acute lymphoblastic leukemia and its clinical use. Review and original data2012 | Second Faculty of Medicine
- Treatment of adult patients with acute lymphoblastic leukemia in the Czech Republic in the period 2007–20202023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Monitoring of Minimal Residual Disease (MRD) by Polymerase Chain Reaction in Patients Treated for B-Cell Nonhodgkin´s lymphomas (NHL) at the 1st Department of Internal Medicine General Faculty Hospital in PraguePublication without faculty affiliation
- Modern approach to the treatment of chronic lymphocytic leukemia2023 | Faculty of Medicine in Hradec Králové
- Fixed duration therapy in patients with chronic lymphocytic leukemia2023 | Publication without faculty affiliation
- Advancements in the treatment of adult acute lymphoblastic leukaemia2015 | Publication without faculty affiliation
- The Clinical Outcome of Patients with B-cell Lymphoproliferative Disease (B-LPD) Seems to Be Improved by the Success in Induction of Polymerase Chain Reaction (PCR) Negativity Achieved by High Dose Therapy with Autologous Stem Cell TransplantPublication without faculty affiliation
- Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring2006 | Second Faculty of Medicine
- Neoadjuvant treatment of breast cancer2017 | First Faculty of Medicine
- Levels of CEA and Ca 19-9 in the sera and peritoneal cavity in patients with gastric and pancreatic cancers2012 | First Faculty of Medicine
- EQUAL-quant: An International External Quality Assessment Scheme for Real-Time PCR2006 | First Faculty of Medicine
- Stanovení diferenciální exprese dlouhých nekódujících RNA z plasmy pacientů s difúzním velkobuněčným B-lymfomem (DLBCL)Publication without faculty affiliation